ARNALDI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 10.271
EU - Europa 4.727
AS - Asia 3.761
SA - Sud America 1.112
Continente sconosciuto - Info sul continente non disponibili 245
AF - Africa 173
OC - Oceania 6
Totale 20.295
Nazione #
US - Stati Uniti d'America 9.975
RU - Federazione Russa 1.423
SG - Singapore 1.246
BR - Brasile 886
VN - Vietnam 872
IT - Italia 780
CN - Cina 598
UA - Ucraina 524
IE - Irlanda 425
SE - Svezia 334
HK - Hong Kong 331
DE - Germania 310
FR - Francia 255
GB - Regno Unito 215
DK - Danimarca 144
FI - Finlandia 140
TR - Turchia 133
CA - Canada 126
BD - Bangladesh 111
IN - India 104
AR - Argentina 85
KR - Corea 73
CI - Costa d'Avorio 51
IQ - Iraq 51
MX - Messico 45
ZA - Sudafrica 41
NL - Olanda 38
VE - Venezuela 33
BE - Belgio 30
EC - Ecuador 30
ID - Indonesia 30
CO - Colombia 29
PK - Pakistan 25
PL - Polonia 24
MA - Marocco 23
IL - Israele 21
JP - Giappone 21
ES - Italia 19
SV - El Salvador 19
PY - Paraguay 18
SA - Arabia Saudita 17
TT - Trinidad e Tobago 17
HN - Honduras 16
UZ - Uzbekistan 16
CR - Costa Rica 15
PH - Filippine 15
GT - Guatemala 14
LT - Lituania 14
CL - Cile 13
IR - Iran 13
CW - ???statistics.table.value.countryCode.CW??? 12
JM - Giamaica 12
EG - Egitto 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
CZ - Repubblica Ceca 9
NI - Nicaragua 9
SC - Seychelles 9
AT - Austria 8
DZ - Algeria 8
JO - Giordania 8
MY - Malesia 8
KZ - Kazakistan 7
PR - Porto Rico 7
RO - Romania 7
UY - Uruguay 7
AZ - Azerbaigian 6
GP - Guadalupe 6
KE - Kenya 6
PE - Perù 6
TH - Thailandia 6
BO - Bolivia 5
LB - Libano 5
NP - Nepal 5
PS - Palestinian Territory 5
AM - Armenia 4
AU - Australia 4
CH - Svizzera 4
EU - Europa 4
OM - Oman 4
BB - Barbados 3
BG - Bulgaria 3
BW - Botswana 3
BZ - Belize 3
HU - Ungheria 3
PT - Portogallo 3
TW - Taiwan 3
AL - Albania 2
BH - Bahrain 2
CG - Congo 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KG - Kirghizistan 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
BY - Bielorussia 1
EE - Estonia 1
Totale 20.046
Città #
Ashburn 1.745
Singapore 826
Chandler 677
Jacksonville 676
San Jose 480
Des Moines 460
Fairfield 425
Dublin 420
Dallas 418
Boardman 360
Council Bluffs 333
Hong Kong 318
Ho Chi Minh City 276
New York 270
Wilmington 221
Hanoi 202
The Dalles 198
Woodbridge 192
Seattle 179
Princeton 168
Ann Arbor 162
Lawrence 161
Los Angeles 161
San Mateo 152
Lauterbourg 148
Houston 147
Beijing 129
Cambridge 128
Moscow 127
São Paulo 108
Centro 93
Orem 73
Hefei 62
Helsinki 62
Santa Clara 61
Milan 59
San Diego 58
South Pasadena 53
Abidjan 51
Rome 48
Chicago 47
Da Nang 47
Turin 44
Montreal 43
London 39
Buffalo 38
Phoenix 36
Shanghai 34
Denver 33
Rio de Janeiro 31
Haiphong 30
San Francisco 30
Chennai 29
Brussels 28
Munich 28
Brooklyn 26
Washington 25
Atlanta 24
Guangzhou 23
Miano 23
Naples 23
Norwalk 23
Baghdad 22
Frankfurt am Main 21
Toronto 21
Biên Hòa 20
Johannesburg 19
Pune 19
San Salvador 19
Columbus 17
Manchester 17
Mumbai 17
Porto Alegre 17
Belo Horizonte 16
Civitanova Marche 16
Tokyo 16
Warsaw 16
Ancona 15
Boston 15
Brasília 15
Caracas 15
Curitiba 15
Dhaka 15
Fortaleza 15
Irving 15
Tashkent 15
Thái Bình 15
Hải Dương 14
Wuhan 14
Mexico City 13
New Bedfont 13
Nuremberg 13
Ribeirão Preto 13
Stockholm 13
Bologna 12
Florence 12
Guayaquil 12
San José 12
Sorocaba 12
Turku 12
Totale 12.179
Nome #
ISOLATION AND CHARACTERIZATION OF MESENCHYMAL CELLS FROM PITUITARY TUMOURS 834
Acromegaly and male sexual health 331
Cushing Syndrome: The Role of MSCs in Wound Healing, Immunosuppression, Comorbidities, and Antioxidant Imbalance 235
Sexual Dysfunctions in Men Affected by Autoimmune Addison's Disease Before and After Short-Term Gluco- and Mineralocorticoid Replacement Therapy 233
Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: the CORTI-COVID study 208
Adrenal incidentaloma: surgical update. 203
Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors. 197
Qualità della vita nei pazienti con sindrome adrenogenitale ed impatto della terapia sostitutiva. 194
Age-related modifications of the human growth hormone circadian secretory pattern studied with a new statistical method in healthy adults 177
Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants. 173
The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study 168
Desmopressin test in the differential diagnosis of Pseudo-Cushing state from Cushing’s disease. 164
Possible influence of melatonin on the human prolactin circadian secretory pattern 164
Effects of long-term treatment with human pure FSH on seminal parameters and sperm cells ultrastructure in idiopathic oligo-asthenozoospermia. 160
Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. 159
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications. 159
Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome 156
The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence” 155
Pituitary adenomas, stem cells, and cancer stem cells: what's new? 152
ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease. 152
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 149
Importance of sleep and melatonin for the human prolactin circadian secretory pattern in normal and pathological conditions 146
RNA sequencing and somatic mutation status of adrenocortical tumors: novel pathogenetic insights 146
Hypothalamic-Pituitary Diseases and Erectile Dysfunction 146
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome 145
Decreased expression of insulin-sensitive glucose transporter mRNA (GLUT-4) in adipose tissue of non-insulin-dependent diabetic and obese patients: evaluation by a simplified quantitative PCR assay. 145
Ruolo dell’osmolarità seminale nella regolazione della motilità degli spermatozoi nell’uomo 140
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency 139
COVID-19 and endocrine and metabolic disorders: critical points and suggestions for a correct therapeutic management from a tertiary endocrine center in Italy 138
Echo Doppler in the characterization of thyroid nodular disease 137
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 137
A novel endothelial tyrosine kinase cDNA homologous to platelet-derived growth factor receptor cDNA. 135
Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. 135
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma 134
How to improve effectiveness of pegvisomant treatment in acromegalic patients 134
Safety and effectiveness of Omnitrope® in patients with growth hormone deficiency: snapshot analysis of PATRO Adults study in the Italian population 134
Unusual clinical manifestation of pheochromocytoma in a MEN2A patient 133
Analisys of Y-linked microdeletions in idiopathic oligo- and azoospermic patients 133
Adrenal incidentaloma. 133
Effects of somatostatin and its analogues on progenitor mesenchymal cells isolated from human pituitary adenomas 133
ADRENAL MORPHO-FUNCTIONAL ALTERATIONS IN PATIENTS WITH ACROMEGALY. 132
Corticotropin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and Pseudo-Cushing state: a comparative study. 132
Androgens in Cushing's Syndrome 132
Impatto della terapia sostitutiva sulla qualità della vita nei pazienti con iperplasia surrenalica congenita. 130
Pachychoroid spectrum disease and choriocapillary flow analysis in patients with Cushing disease: an optical coherence tomography angiography study 129
Diagnosis and complications of Cushing's syndrome: a consensus statement 128
Coenzyme Q10 levels in idiopathic and varicocele-associated asthenozoospermia 126
An evaluation of the ultrastructural features improvement in idiopathic oligo-astenospermia after FSH treatment 126
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion 125
Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group. 124
Is pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis 123
Glucocorticoid excess and COVID-19 disease 123
ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas. 122
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome 122
Enhanced expression of transforming growth factor beta 1 in rat thyroid hyperplasia is thyrotropin induced and time dependent 121
Acromegalia e Ancona: un fil rouge lungo trecento anni, da Amato Lusitano ad Augusto Tamburini 120
Fine-needle aspiration cytology of adrenal masses: a re-assessment with histological confirmation. 120
A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. 120
Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease 119
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 119
Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation. 118
[Cytological diagnosis of thyroid nodules. Comparison of results obtained with guided echography with those from of a "blind" biopsy]. 117
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 117
Self image and quality of life in acromegaly 116
Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial 116
New treatment guidelines on Cushing's disease. 115
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas. 115
Adrenal incidentaloma. 114
High cardiovascular risk in patients with Cushing's syndrome accorìging to 1999 WHO/ISH guidelines 114
Determinazione comparativa dei livelli del coenzima Q10 nelle oligozoospermie idiopatiche e nel varicocele 113
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. 113
Isolation and characterization of Mesenchymal Stem Cells from pituitary tumours 112
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. 112
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: A multicenter study 111
Pituitary adenoma apoplexy: Review of personal series. 111
High-dose and high-frequency lanreotide autogel in acromegaly: A randomized, multicenter study 111
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 111
[Anti-microsomal, anti-thyroglobulin antibodies and thyroid stimulants in hyperthyroid subjects. Analysis of 315 patients followed-up for 3 years at a single medical center]. 110
Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing Syndrome 109
[Pulsar analysis of the 24-hour secretion of GH in normal subjects, in acromegalics and in patients with non-secreting and prolactin-secreting pituitary adenoma]. 107
Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia. 107
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome 107
Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma. 106
Semen osmolarity and sperm motility 106
Structural Analysis of Social Behavior: Using Cluster Analysis to Examine Intrapsychic Personality Traits Associated With Depression in Women With Breast Cancer 106
Osilodrostat oral tablets for adults with Cushing's disease 105
Cortisolo in seminal plasma: a potential addition to the multidimensional approach to male infertility. 105
A Single-Center 10-Year Experience with Pasireotide in Cushing's Disease: Patients' Characteristics and Outcome. 105
Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor. 104
Acromegaly Is More Severe in Patients With AHR or AIP Gene Variants Living in Highly Polluted Areas 103
High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. 103
Structural analysis of social behavior: Using cluster analysis to examine personality profile associated with diabetes onset 102
Cardiovascular risk in Cushing's syndrome. 102
The role of an acute pasireotide suppression test in predicting response to treatment in patients with Cushing’s disease: findings from a pilot study 102
Functional and nonfunctional adrenocortical tumors demonstrate a high responsiveness to low-dose adrenocorticotropin. 101
Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status. 101
AME position statement on adrenal incidentaloma. 99
Effects of hypertension and aging on platelet-derived growth factor and platelet-derived growth factor receptor expression in rat aorta and heart. 98
Intrapituitary cytokines in Cushing's disease: do they play a role? 98
Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. 98
Totale 13.959
Categoria #
all - tutte 97.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.538


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022755 0 0 0 0 7 77 41 90 80 101 101 258
2022/20232.311 210 232 165 174 108 609 6 103 525 11 120 48
2023/20241.356 236 45 120 178 214 272 38 31 7 40 20 155
2024/20252.336 321 223 81 26 65 56 282 91 521 179 228 263
2025/20267.571 408 523 405 791 682 444 1.235 710 1.282 552 194 345
2026/20272.182 257 366 608 902 49 0 0 0 0 0 0 0
Totale 20.295